相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Editorial: Regulation of Immunity by Non-Immune Cells
Teruki Dainichi et al.
FRONTIERS IN IMMUNOLOGY (2021)
High-content image-based analysis and proteomic profiling identifies Tau phosphorylation inhibitors in a human iPSC-derived glutamatergic neuronal model of tauopathy
Chialin Cheng et al.
SCIENTIFIC REPORTS (2021)
LPS induces ALOX5 promoter activation and 5-lipoxygenase expression in human monocytic cells
Samuel J. Poirier et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2020)
Proteasomal degradation of the intrinsically disordered protein tau at single-residue resolution
T. Ukmar-Godec et al.
SCIENCE ADVANCES (2020)
Proteasome Activation as a New Therapeutic Approach To Target Proteotoxic Disorders
Evert Njomen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
The proteostasis network and its decline in ageing
Mark S. Hipp et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
26S Proteasomes are rapidly activated by diverse hormones and physiological states that raise cAMP and cause Rpn6 phosphorylation
Jordan J. S. VerPlank et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Methods to Discover and Evaluate Proteasome Small Molecule Stimulators
Rachel A. Coleman et al.
MOLECULES (2019)
Targeting the ensemble of heterogeneous tau oligomers in cells: A novel small molecule screening platform for tauopathies
Chih Hung Lo et al.
ALZHEIMERS & DEMENTIA (2019)
Compromised function of the ESCRT pathway promotes endolysosomal escape of tau seeds and propagation of tau aggregation
John J. Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Regulation of Autophagic Flux by the 20S Proteasome
Evert Njomen et al.
CELL CHEMICAL BIOLOGY (2019)
Tau-targeting therapies for Alzheimer disease
Erin E. Congdon et al.
NATURE REVIEWS NEUROLOGY (2018)
Brain 5-lipoxygenase over-expression worsens memory, synaptic integrity, and tau pathology in the P301S mice
Alana N. Vagnozzi et al.
AGING CELL (2018)
Interplay of pathogenic forms of human tau with different autophagic pathways
Benjamin Caballero et al.
AGING CELL (2018)
The direct role of 5-lipoxygenase on tau pathology, synaptic integrity and cognition in a mouse model of tauopathy
Alana N. Vagnozzi et al.
TRANSLATIONAL PSYCHIATRY (2017)
Protein misfolding in neurodegenerative diseases: implications and strategies
Patrick Sweeney et al.
TRANSLATIONAL NEURODEGENERATION (2017)
Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease
Laurie A. Robak et al.
BRAIN (2017)
Establishment of a suite of assays that support the discovery of proteasome stimulators
Darci J. Trader et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2017)
A LUHMES 3D dopaminergic neuronal model for neurotoxicity testing allowing long-term exposure and cellular resilience analysis
L. Smirnova et al.
ARCHIVES OF TOXICOLOGY (2016)
Coordinate regulation of autophagy and the ubiquitin proteasome system by MTOR
Jinghui Zhao et al.
AUTOPHAGY (2016)
An Autophagic Flux Probe that Releases an Internal Control
Takeshi Kaizuka et al.
MOLECULAR CELL (2016)
Tau downregulates BDNF expression in animal and cellular models of Alzheimer's disease
Elyse Rosa et al.
NEUROBIOLOGY OF AGING (2016)
α-Synuclein-induced lysosomal dysfunction occurs through disruptions in protein trafficking in human midbrain synucleinopathy models
Joseph R. Mazzulli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Neuroinflammation in Alzheimer's disease
Michael T. Heneka et al.
LANCET NEUROLOGY (2015)
5-Lipoxygenase Inhibitors Attenuate TNF-α-Induced Inflammation in Human Synovial Fibroblasts
Han-Ching Lin et al.
PLOS ONE (2014)
Proteasome Inhibitors Alter Levels of Intracellular Peptides in HEK293T and SH-SY5Y Cells
Sayani Dasgupta et al.
PLOS ONE (2014)
The 12-15-lipoxygenase is a modulator of Alzheimer's-related tau pathology in vivo
Phillip F. Giannopoulos et al.
AGING CELL (2013)
5-Lipoxygenase Activating Protein Reduction Ameliorates Cognitive Deficit, Synaptic Dysfunction, and Neuropathology in a Mouse Model of Alzheimer's Disease
Phillip F. Giannopoulos et al.
BIOLOGICAL PSYCHIATRY (2013)
Modulation of 5-Lipoxygenase in Proteotoxicity and Alzheimer's Disease
Elvira Valera et al.
JOURNAL OF NEUROSCIENCE (2013)
Tau degradation: The ubiquitin-proteasome system versus the autophagy-lysosome system
Min Jae Lee et al.
PROGRESS IN NEUROBIOLOGY (2013)
FLAP pharmacological blockade modulates metabolism of endogenous tau in vivo
J. Chu et al.
TRANSLATIONAL PSYCHIATRY (2013)
Induced Tauopathy in a Novel 3D-Culture Model Mediates Neurodegenerative Processes: A Real-Time Study on Biochips
Diana Seidel et al.
PLOS ONE (2012)
Pharmacologic Blockade of 5-Lipoxygenase Improves the Amyloidotic Phenotype of an Alzheimer's Disease Transgenic Mouse Model Involvement of γ-Secretase
Jin Chu et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
5-Lipoxygenase as an Endogenous Modulator of Amyloid beta Formation In Vivo
Jin Chu et al.
ANNALS OF NEUROLOGY (2011)
Proteasome Inhibition Drives HDAC6-Dependent Recruitment of Tau to Aggresomes
Chris R. Guthrie et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2011)
Amyloid-β Peptide Is a Substrate of the Human 20S Proteasome
Xiaobei Zhao et al.
ACS CHEMICAL NEUROSCIENCE (2010)
Mechanisms of cross-talk between the ubiquitin-proteasome and autophagy-lysosome systems
Viktor I. Korolchuk et al.
FEBS LETTERS (2010)
Proteasome inhibitors activate autophagy as a cytoprotective response in human prostate cancer cells
K. Zhu et al.
ONCOGENE (2010)
A Cellular Model To Monitor Proteasome Dysfunction by α-Synuclein
Takashi Nonaka et al.
BIOCHEMISTRY (2009)
Autophagy Inhibition Compromises Degradation of Ubiquitin-Proteasome Pathway Substrates
Viktor I. Korolchuk et al.
MOLECULAR CELL (2009)
Limitations of SLLVY-AMC in calpain and proteasome measurements
Christopher J. Giguere et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Docking of the proteasomal ATPases' carboxyl termini in the 20S proteasome's α ring opens the gate for substrate entry
David M. Smith et al.
MOLECULAR CELL (2007)
Fatty acid release and oxidation are factors in lipoxygenase inhibitor-induced apoptosis
E La et al.
TOXICOLOGY LETTERS (2003)
Toxicity of human monocytic THP-1 cells and microglia toward SH-SY5Y neuroblastoma cells is reduced by inhibitors of 5-lipoxygenase and its activating protein FLAP
A Klegeris et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
Endoproteolytic activity of the proteasome
CW Liu et al.
SCIENCE (2003)
Proteasomal degradation of tau protein
DC David et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Neurotrophins: Roles in neuronal development and function
EJ Huang et al.
ANNUAL REVIEW OF NEUROSCIENCE (2001)
Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells
M Encinas et al.
JOURNAL OF NEUROCHEMISTRY (2000)
分享论文
